Patients with diabetes and prediabetes have widespread insulin resistance, which blocks insulin signaling pathways such as PI3K/Ak [35] and Ras-MAPK [36], thus cannot effectively promote the uptake of amino acids by muscle cells, thereby inhibiting the synthesis of muscle proteins; this results in a decrease in muscle mass. The gene discussed is INS; the disease is diabetes mellitus.